Metraipolis › archive › dc_de2351fe4d29
Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database — Europe PMC PMID:41808830
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41808830
- DOI
- 10.3389/fimmu.2026.1769109
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T04:41:16.368Z
- SHA-256 of the archived text
92dccfbbc8dfc40c0ef24001f87ad93260c1e8f49b278d06bb2350527979b81b- Stable URL of this page
https://metraipolis.com/documento/dc_de2351fe4d29
How to cite
Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database — Europe PMC PMID:41808830 — Europe PMC (en), https://europepmc.org/article/MED/41808830 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de2351fe4d29 (Metraipolis archive dc_de2351fe4d29, sha256 92dccfbbc8dfc40c0ef24001f87ad93260c1e8f49b278d06bb2350527979b81b)
BibTeX
@misc{dcde2351fe4d29,
title = {Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database — Europe PMC PMID:41808830},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41808830},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de2351fe4d29; sha256 92dccfbbc8dfc40c0ef24001f87ad93260c1e8f49b278d06bb2350527979b81b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41808830. Agents can read the archived copy with the MCP tool read_document.